Mahamaya Lifesciences Ltd
ncorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management.[1]
- Market Cap ₹ 425 Cr.
- Current Price ₹ 182
- High / Low ₹ 205 / 111
- Stock P/E 30.2
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 25.9 %
- ROE 34.9 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.5%
Cons
- Debtor days have increased from 52.1 to 67.0 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE SME IPO
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 90 | 137 | 161 | 264 | |
| 84 | 128 | 148 | 241 | |
| Operating Profit | 6 | 9 | 13 | 23 |
| OPM % | 7% | 6% | 8% | 9% |
| 0 | 0 | 1 | 3 | |
| Interest | 2 | 3 | 6 | 7 |
| Depreciation | 1 | 1 | 1 | 2 |
| Profit before tax | 4 | 5 | 7 | 17 |
| Tax % | 27% | 26% | 27% | 25% |
| 3 | 4 | 5 | 13 | |
| EPS in Rs | 21.78 | 30.03 | 41.80 | 7.28 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 43% |
| TTM: | 63% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 68% |
| TTM: | 149% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 29% |
| Last Year: | 35% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 18 | 18 |
| Reserves | 14 | 18 | 23 | 32 | 40 |
| 19 | 24 | 55 | 58 | 68 | |
| 21 | 34 | 33 | 81 | 110 | |
| Total Liabilities | 56 | 78 | 112 | 188 | 236 |
| 20 | 21 | 21 | 27 | 31 | |
| CWIP | 2 | 2 | 3 | 4 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 34 | 54 | 88 | 157 | 205 | |
| Total Assets | 56 | 78 | 112 | 188 | 236 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 2 | 1 | -23 | 1 | |
| -3 | -3 | -2 | -8 | |
| 1 | 2 | 24 | 9 | |
| Net Cash Flow | 0 | 1 | -0 | 1 |
| Free Cash Flow | -1 | -2 | -25 | -8 |
| CFO/OP | 56% | 24% | -163% | 12% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 37 | 25 | 64 | 67 |
| Inventory Days | 93 | 109 | 137 | 167 |
| Days Payable | 83 | 87 | 61 | 92 |
| Cash Conversion Cycle | 47 | 48 | 140 | 142 |
| Working Capital Days | 8 | 9 | 14 | 29 |
| ROCE % | 20% | 21% | 26% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
5 May - Company says Annual Secretarial Compliance Report for FY2026 is not applicable under Regulation 24A.
- Intimation Under Regulation 30 (LODR)_Certificate Of Appreciation 4 May
-
Announcement Under Regulation 30(LODR)-Receiving A Certification-"Great Place To Work
28 Apr - Awarded Great Place to Work certification for Under 100 Employees, valid April 2026 to April 2027.
-
Non-Applicability Of The Compliance On Corporate Governance As Required Under Regulation 27(2) Of SEBI (LODR) Regulations 2015
15 Apr - Company says Regulation 27(2) corporate governance report not applicable under SME exemption.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
4 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026; all shares remain in demat form.
Annual reports
No data available.
Business Profile[1]
The company manufactures pesticide formulations and supplies bulk products to Indian agrochemical companies and multinational corporations (MNCs). It imports scientifically researched molecules, secures registrations with the Central Insecticides Board, and develops these molecules into technical-grade and value-added formulations, which are marketed to domestic manufacturers and global MNCs.